| FRANKLIN DISRUPTIVE COMMERCE N (ACC) EUR | RVI CONSUMO | -13,69% | 33,01% | · | · |
| FRANKLIN DISRUPTIVE COMMERCE N (ACC) USD | RVI CONSUMO | -14,31% | 32,62% | · | · |
| FRANKLIN DISRUPTIVE COMMERCE W (ACC) USD | RVI CONSUMO | -12,94% | 39,44% | · | · |
| FRANKLIN EMERGING MARKET CORPORATE DEBT P2 (ACC) USD | DEUDA PRIVADA EMERGENTES | 7,59% | · | · | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (ACC) EUR | RFI EUROPA | -0,98% | · | · | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (ACC) USD-H1 | RFI EUROPA | 4,09% | · | · | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (MDIS) EUR | RFI EUROPA | -4,04% | · | · | · |
| FRANKLIN EUROPEAN TOTAL RETURN S (MDIS) USD-H1 | RFI EUROPA | 0,95% | · | · | · |
| FRANKLIN EURO SHORT DURATION BOND EB (QDIS) EUR | RF EURO CORTO PLAZO | -2,24% | 0,50% | · | · |
| FRANKLIN EURO SHORT DURATION BOND S (ACC) EUR | RF EURO CORTO PLAZO | 0,46% | 9,52% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) EUR-H1 | RVI BIOTECNOLOGÍA | 25,07% | 37,65% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (ACC) USD | RVI BIOTECNOLOGÍA | 31,89% | 37,34% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS A (YDIS) EUR | RVI BIOTECNOLOGÍA | 32,74% | 37,65% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS C (ACC) USD | RVI BIOTECNOLOGÍA | 31,01% | 35,08% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) EUR | RVI BIOTECNOLOGÍA | 34,12% | 41,65% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS I (ACC) USD | RVI BIOTECNOLOGÍA | 33,08% | 41,35% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) EUR | RVI BIOTECNOLOGÍA | 31,77% | 34,70% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS N (ACC) USD | RVI BIOTECNOLOGÍA | 30,64% | 34,27% | · | · |
| FRANKLIN GENOMIC ADVANCEMENTS W (ACC) USD | RVI BIOTECNOLOGÍA | 32,96% | 41,27% | · | · |
| FRANKLIN GLOBAL GREEN BOND S (ACC) EUR | RFI GLOBAL | -1,64% | 9,87% | · | · |
